Carl Sailer Biography and Net Worth

Mr. Sailer’s career extends almost 30 years as a commercial leader in the biopharmaceutical industry. He is currently Senior Vice President, Global Client Solutions for Syneos Health, a fully integrated biopharmaceutical solutions company that is expertised in taking new therapies to market, from clinical stage through commercial stage.  Mr. Sailer leads global customer-centric commercial account teams for two of the company's leading large pharma clients. Prior to Syneos Health, Mr. Sailer served as the Vice President of Sales and Marketing for Emisphere Technologies (ultimately acquired by Novo Nordisk), Vice President of Commercial Operations at New American Therapeutics (ultimately acquired by Renaissance Pharma) and Akrimax Pharmaceuticals, in each case, where he built and led the commercial organizations for each start-up company.

Previously, Mr. Sailer was a member of the Executive Committee at PDI, a leading contract commercial organization, where he held several leadership positions in product commercialization and business development. Mr. Sailer started his career by holding various sales, marketing and sales management roles in the pharmaceutical and consumer products divisions of Bristol-Myers Squibb and Bayer Healthcare.

Mr. Sailer earned an MBA from Hofstra University, and a BS in marketing with a minor in journalism from Seton Hall University, where he has been an adjunct graduate school professor and currently serves on the Advisory Board of the Market Research Center at the Stillman School of Business.